Discovery of MMP activated peptide-doxorubicin prodrugs as anti-tumor agents: Part I

被引：0
|
作者：
Han, Wei
Jiang, XiangJun
Hu, Zilun
Graciani, Nilsa
Albright, Charles F.
Yue, Eddy
Zhang, Mingzhu
Dowling, Randine
Huang, Pearl
Oliff, Allen
Copeland, Robert A.
Trainor, George L.
Combs, Andrew P.
Seitz, Steven P.
机构：
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] GlaxoSmithKline Inc, Stevenage, Herts, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
271-MEDI
引用
收藏
页数：2
相关论文
共 49 条
  • [1] Discovery of MMP activated peptide-doxorubicin prodrugs as anti-tumor agents: Part II
    Han, Wei
    Hu, Zilun
    Jiang, XiangJun
    Albright, Charles F.
    Zhang, Shu-Yun
    Graciani, Nilsa
    Zhang, Mingzhu
    Yeleswaram, Swamy
    Huang, Pearl
    Oliff, Alan
    Trainor, George L.
    Combs, Andrew P.
    Seitz, Steven P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [2] Discovery of matrix metalloproteases selective and activated peptide-doxorubicin prodrugs as anti-tumor agents
    Hu, Zilun
    Jiang, Xiangjun
    Albright, Charles F.
    Graciani, Nilsa
    Yue, Eddy
    Zhang, Mingzhu
    Zhang, Shu-Yun
    Bruckner, Robert
    Diamond, Melody
    Dowling, Randine
    Rafalski, Maria
    Yeleswaram, Swamy
    Trainor, George L.
    Seitz, Steven P.
    Han, Wei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 853 - 856
  • [3] DISCOVERY OF ANTI-TUMOR AGENTS FROM NATURAL SOURCES
    SUFFNESS, M
    DOUROS, JD
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (11) : 307 - 310
  • [4] Tumor-activated prodrugs of potent taxanes: Anti-cancer agents with low toxicity and enhanced specificity and anti-tumor activity.
    Chari, RV
    Xie, H
    Wilhelm, SD
    Leece, BA
    Bartle, LM
    Goldmacher, VS
    Geng, X
    Wu, X
    Ojima, I
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3676S - 3676S
  • [5] INTERACTION OF ALKYLATING ANTI-TUMOR AGENTS WITH ACTIVATED ONCOGENES IN HUMAN-TUMOR CELLS
    FUTSCHER, BW
    ERICKSON, LC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 17 - 17
  • [6] Drug Discovery for Novel Anti-Tumor Agents targeting One Carbon Metabolism
    Asai, Ayumu
    Konno, Masamitsu
    Koseki, Jun
    Gotoh, Noriko
    Satoh, Taroh
    Doki, Yuichiro
    Mori, Masaki
    Ishii, Hideshi
    CANCER SCIENCE, 2018, 109 : 260 - 260
  • [7] New design for twin reactive oxygen species activated anti-tumor agents
    Zhu, Haizhou
    Salam, Safnas Farwin Abdul
    Liu, Jing
    Merino, Edward
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [8] A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
    DeFeo-Jones, D
    Garsky, VM
    Wong, BK
    Feng, DM
    Bolyar, T
    Haskell, K
    Kiefer, DM
    Leander, K
    McAvoy, E
    Lumma, P
    Wai, J
    Senderak, ET
    Motzel, SL
    Keenan, K
    Van Zwieten, M
    Lin, JH
    Freidinger, R
    Huff, J
    Oliff, A
    Jones, RE
    NATURE MEDICINE, 2000, 6 (11) : 1248 - 1252
  • [9] Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents
    He, Huining
    Sun, Lu
    Ye, Junxiao
    Liu, Ergang
    Chen, Sunhui
    Liang, Qiuling
    Shin, Meong Cheol
    Yang, Victor C.
    JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 67 - 76
  • [10] Heterogeneity of Anticitrullinated Peptide Antibodies and Response to Anti-Tumor Necrosis Factor Agents in Rheumatoid Arthritis
    Fisher, Benjamin A.
    Plant, Darren
    Lundberg, Karin
    Charles, Peter
    Barton, Anne
    Venables, Patrick J.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (05) : 929 - 932
12345